BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Third Quarter 2014 Financial Results On October 27, 2014 10/14/2014 12:23:31 PM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Second Quarter 2014 Results 8/7/2014 9:34:19 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Second Quarter 2014 Financial Results On August 7, 2014 7/18/2014 10:03:14 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: European Medicines Agency Accepts HETLIOZ™ (Tasimelteon) Marketing Authorization Application For Non-24-Hour Sleep-Wake Disorder In The Totally Blind 6/3/2014 9:26:31 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 6:53:36 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports First Quarter 2014 Results 5/8/2014 7:12:07 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce First Quarter 2014 Financial Results On May 8, 2014 4/25/2014 6:39:08 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014 9:44:15 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2013 And Full Year 2013 Results 2/13/2014 11:14:10 AM
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™ 2/3/2014 6:44:54 AM
12345678910...